The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Brain Cancer Treatment Devices Market Research Report 2025
Synopsis
Brain cancer treatment devices refer to the medical equipment and technologies used in the diagnosis, treatment, and management of brain cancer. These devices aim to assist healthcare professionals in effectively treating brain tumors and improving patient outcomes.
Global Brain Cancer Treatment Devices market is projected to reach US$ 2074.3 million in 2029, increasing from US$ 1300 million in 2022, with the CAGR of 6.9% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Brain Cancer Treatment Devices market research.
The global brain cancer treatment devices market refers to the overall market for medical devices used in the treatment of brain cancer. This market encompasses various products and technologies aimed at diagnosing, treating, and managing brain tumors.
Currently, the brain cancer treatment devices market is experiencing growth due to several factors such as the increasing incidence of brain cancer cases, advancements in medical technology, and a growing emphasis on early diagnosis and effective treatment.
Some key factors driving the market growth include:
Rising Incidence of Brain Cancer: The increasing prevalence of brain cancer worldwide is a significant factor propelling the demand for brain cancer treatment devices. Factors such as lifestyle changes, environmental factors, and genetic predisposition contribute to the growing incidence of brain tumors.
Technological Advancements: Continuous advancements in medical technology have led to the development of innovative brain cancer treatment devices. These devices offer enhanced precision, improved treatment outcomes, and reduced risks for patients.
Favorable Reimbursement Policies: Improvements in reimbursement policies for brain cancer treatments, especially in developed countries, have positively impacted the adoption of advanced treatment devices. This has made these devices more accessible and affordable for patients.
Increasing Awareness and Early Diagnosis: Growing awareness about brain cancer symptoms and the importance of early diagnosis has resulted in a higher demand for diagnostic devices such as MRI and CT scanners. Early detection enables timely treatment, improving patient prognosis.
Collaborative Initiatives and Research: Research collaborations between medical device manufacturers, research institutions, and healthcare providers have led to the development of novel treatment devices. These initiatives aim to improve treatment outcomes and patient care.
North America and Europe currently dominate the brain cancer treatment devices market due to well-established healthcare infrastructure, reimbursement policies, and higher healthcare expenditure. However, with increasing awareness, improving healthcare infrastructure, and a growing focus on healthcare in emerging economies, the market is projected to witness significant growth in Asia-Pacific and other regions.
The global brain cancer treatment devices market is expected to experience continuous growth in the coming years as medical technology advances and efforts to combat brain cancer intensify.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Brain Cancer Treatment Devices market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Accuray Incorporated
BrainLAB AG
CarThera SAS
Elekta
GT Medical Technologies
iCAD Inc.
Integra LifeSciences
MagForce
Medtronic
Monteris Medical
Novocure GmbH
Thermo Fisher Scientific
Varian Medical Systems
Segment by Type
Directional Energy Therapy Equipment
Drug/Fluid Delivery and Infusion Therapy Devices
Others
`
Segment by Application
Hospital
Outpatient Surgery Center
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Brain Cancer Treatment Devices report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Brain cancer treatment devices refer to the medical equipment and technologies used in the diagnosis, treatment, and management of brain cancer. These devices aim to assist healthcare professionals in effectively treating brain tumors and improving patient outcomes.
Global Brain Cancer Treatment Devices market is projected to reach US$ 2074.3 million in 2029, increasing from US$ 1300 million in 2022, with the CAGR of 6.9% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Brain Cancer Treatment Devices market research.
The global brain cancer treatment devices market refers to the overall market for medical devices used in the treatment of brain cancer. This market encompasses various products and technologies aimed at diagnosing, treating, and managing brain tumors.
Currently, the brain cancer treatment devices market is experiencing growth due to several factors such as the increasing incidence of brain cancer cases, advancements in medical technology, and a growing emphasis on early diagnosis and effective treatment.
Some key factors driving the market growth include:
Rising Incidence of Brain Cancer: The increasing prevalence of brain cancer worldwide is a significant factor propelling the demand for brain cancer treatment devices. Factors such as lifestyle changes, environmental factors, and genetic predisposition contribute to the growing incidence of brain tumors.
Technological Advancements: Continuous advancements in medical technology have led to the development of innovative brain cancer treatment devices. These devices offer enhanced precision, improved treatment outcomes, and reduced risks for patients.
Favorable Reimbursement Policies: Improvements in reimbursement policies for brain cancer treatments, especially in developed countries, have positively impacted the adoption of advanced treatment devices. This has made these devices more accessible and affordable for patients.
Increasing Awareness and Early Diagnosis: Growing awareness about brain cancer symptoms and the importance of early diagnosis has resulted in a higher demand for diagnostic devices such as MRI and CT scanners. Early detection enables timely treatment, improving patient prognosis.
Collaborative Initiatives and Research: Research collaborations between medical device manufacturers, research institutions, and healthcare providers have led to the development of novel treatment devices. These initiatives aim to improve treatment outcomes and patient care.
North America and Europe currently dominate the brain cancer treatment devices market due to well-established healthcare infrastructure, reimbursement policies, and higher healthcare expenditure. However, with increasing awareness, improving healthcare infrastructure, and a growing focus on healthcare in emerging economies, the market is projected to witness significant growth in Asia-Pacific and other regions.
The global brain cancer treatment devices market is expected to experience continuous growth in the coming years as medical technology advances and efforts to combat brain cancer intensify.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Brain Cancer Treatment Devices market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Accuray Incorporated
BrainLAB AG
CarThera SAS
Elekta
GT Medical Technologies
iCAD Inc.
Integra LifeSciences
MagForce
Medtronic
Monteris Medical
Novocure GmbH
Thermo Fisher Scientific
Varian Medical Systems
Segment by Type
Directional Energy Therapy Equipment
Drug/Fluid Delivery and Infusion Therapy Devices
Others
`
Segment by Application
Hospital
Outpatient Surgery Center
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Brain Cancer Treatment Devices report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Brain Cancer Treatment Devices Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Directional Energy Therapy Equipment
1.2.3 Drug/Fluid Delivery and Infusion Therapy Devices
1.2.4 Others
1.2.6 `
1.3 Market by Application
1.3.1 Global Brain Cancer Treatment Devices Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Outpatient Surgery Center
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Brain Cancer Treatment Devices Market Perspective (2018-2029)
2.2 Brain Cancer Treatment Devices Growth Trends by Region
2.2.1 Global Brain Cancer Treatment Devices Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Brain Cancer Treatment Devices Historic Market Size by Region (2018-2023)
2.2.3 Brain Cancer Treatment Devices Forecasted Market Size by Region (2024-2029)
2.3 Brain Cancer Treatment Devices Market Dynamics
2.3.1 Brain Cancer Treatment Devices Industry Trends
2.3.2 Brain Cancer Treatment Devices Market Drivers
2.3.3 Brain Cancer Treatment Devices Market Challenges
2.3.4 Brain Cancer Treatment Devices Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Brain Cancer Treatment Devices Players by Revenue
3.1.1 Global Top Brain Cancer Treatment Devices Players by Revenue (2018-2023)
3.1.2 Global Brain Cancer Treatment Devices Revenue Market Share by Players (2018-2023)
3.2 Global Brain Cancer Treatment Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Brain Cancer Treatment Devices Revenue
3.4 Global Brain Cancer Treatment Devices Market Concentration Ratio
3.4.1 Global Brain Cancer Treatment Devices Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Brain Cancer Treatment Devices Revenue in 2022
3.5 Brain Cancer Treatment Devices Key Players Head office and Area Served
3.6 Key Players Brain Cancer Treatment Devices Product Solution and Service
3.7 Date of Enter into Brain Cancer Treatment Devices Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Brain Cancer Treatment Devices Breakdown Data by Type
4.1 Global Brain Cancer Treatment Devices Historic Market Size by Type (2018-2023)
4.2 Global Brain Cancer Treatment Devices Forecasted Market Size by Type (2024-2029)
5 Brain Cancer Treatment Devices Breakdown Data by Application
5.1 Global Brain Cancer Treatment Devices Historic Market Size by Application (2018-2023)
5.2 Global Brain Cancer Treatment Devices Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Brain Cancer Treatment Devices Market Size (2018-2029)
6.2 North America Brain Cancer Treatment Devices Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Brain Cancer Treatment Devices Market Size by Country (2018-2023)
6.4 North America Brain Cancer Treatment Devices Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Brain Cancer Treatment Devices Market Size (2018-2029)
7.2 Europe Brain Cancer Treatment Devices Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Brain Cancer Treatment Devices Market Size by Country (2018-2023)
7.4 Europe Brain Cancer Treatment Devices Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Brain Cancer Treatment Devices Market Size (2018-2029)
8.2 Asia-Pacific Brain Cancer Treatment Devices Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Brain Cancer Treatment Devices Market Size by Region (2018-2023)
8.4 Asia-Pacific Brain Cancer Treatment Devices Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Brain Cancer Treatment Devices Market Size (2018-2029)
9.2 Latin America Brain Cancer Treatment Devices Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Brain Cancer Treatment Devices Market Size by Country (2018-2023)
9.4 Latin America Brain Cancer Treatment Devices Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Brain Cancer Treatment Devices Market Size (2018-2029)
10.2 Middle East & Africa Brain Cancer Treatment Devices Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Brain Cancer Treatment Devices Market Size by Country (2018-2023)
10.4 Middle East & Africa Brain Cancer Treatment Devices Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Accuray Incorporated
11.1.1 Accuray Incorporated Company Detail
11.1.2 Accuray Incorporated Business Overview
11.1.3 Accuray Incorporated Brain Cancer Treatment Devices Introduction
11.1.4 Accuray Incorporated Revenue in Brain Cancer Treatment Devices Business (2018-2023)
11.1.5 Accuray Incorporated Recent Development
11.2 BrainLAB AG
11.2.1 BrainLAB AG Company Detail
11.2.2 BrainLAB AG Business Overview
11.2.3 BrainLAB AG Brain Cancer Treatment Devices Introduction
11.2.4 BrainLAB AG Revenue in Brain Cancer Treatment Devices Business (2018-2023)
11.2.5 BrainLAB AG Recent Development
11.3 CarThera SAS
11.3.1 CarThera SAS Company Detail
11.3.2 CarThera SAS Business Overview
11.3.3 CarThera SAS Brain Cancer Treatment Devices Introduction
11.3.4 CarThera SAS Revenue in Brain Cancer Treatment Devices Business (2018-2023)
11.3.5 CarThera SAS Recent Development
11.4 Elekta
11.4.1 Elekta Company Detail
11.4.2 Elekta Business Overview
11.4.3 Elekta Brain Cancer Treatment Devices Introduction
11.4.4 Elekta Revenue in Brain Cancer Treatment Devices Business (2018-2023)
11.4.5 Elekta Recent Development
11.5 GT Medical Technologies
11.5.1 GT Medical Technologies Company Detail
11.5.2 GT Medical Technologies Business Overview
11.5.3 GT Medical Technologies Brain Cancer Treatment Devices Introduction
11.5.4 GT Medical Technologies Revenue in Brain Cancer Treatment Devices Business (2018-2023)
11.5.5 GT Medical Technologies Recent Development
11.6 iCAD Inc.
11.6.1 iCAD Inc. Company Detail
11.6.2 iCAD Inc. Business Overview
11.6.3 iCAD Inc. Brain Cancer Treatment Devices Introduction
11.6.4 iCAD Inc. Revenue in Brain Cancer Treatment Devices Business (2018-2023)
11.6.5 iCAD Inc. Recent Development
11.7 Integra LifeSciences
11.7.1 Integra LifeSciences Company Detail
11.7.2 Integra LifeSciences Business Overview
11.7.3 Integra LifeSciences Brain Cancer Treatment Devices Introduction
11.7.4 Integra LifeSciences Revenue in Brain Cancer Treatment Devices Business (2018-2023)
11.7.5 Integra LifeSciences Recent Development
11.8 MagForce
11.8.1 MagForce Company Detail
11.8.2 MagForce Business Overview
11.8.3 MagForce Brain Cancer Treatment Devices Introduction
11.8.4 MagForce Revenue in Brain Cancer Treatment Devices Business (2018-2023)
11.8.5 MagForce Recent Development
11.9 Medtronic
11.9.1 Medtronic Company Detail
11.9.2 Medtronic Business Overview
11.9.3 Medtronic Brain Cancer Treatment Devices Introduction
11.9.4 Medtronic Revenue in Brain Cancer Treatment Devices Business (2018-2023)
11.9.5 Medtronic Recent Development
11.10 Monteris Medical
11.10.1 Monteris Medical Company Detail
11.10.2 Monteris Medical Business Overview
11.10.3 Monteris Medical Brain Cancer Treatment Devices Introduction
11.10.4 Monteris Medical Revenue in Brain Cancer Treatment Devices Business (2018-2023)
11.10.5 Monteris Medical Recent Development
11.11 Novocure GmbH
11.11.1 Novocure GmbH Company Detail
11.11.2 Novocure GmbH Business Overview
11.11.3 Novocure GmbH Brain Cancer Treatment Devices Introduction
11.11.4 Novocure GmbH Revenue in Brain Cancer Treatment Devices Business (2018-2023)
11.11.5 Novocure GmbH Recent Development
11.12 Thermo Fisher Scientific
11.12.1 Thermo Fisher Scientific Company Detail
11.12.2 Thermo Fisher Scientific Business Overview
11.12.3 Thermo Fisher Scientific Brain Cancer Treatment Devices Introduction
11.12.4 Thermo Fisher Scientific Revenue in Brain Cancer Treatment Devices Business (2018-2023)
11.12.5 Thermo Fisher Scientific Recent Development
11.13 Varian Medical Systems
11.13.1 Varian Medical Systems Company Detail
11.13.2 Varian Medical Systems Business Overview
11.13.3 Varian Medical Systems Brain Cancer Treatment Devices Introduction
11.13.4 Varian Medical Systems Revenue in Brain Cancer Treatment Devices Business (2018-2023)
11.13.5 Varian Medical Systems Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
